Reversal of hepatic myelopathy after liver transplantation: Fifteen plus one
β Scribed by Umberto Baccarani; Erika Zola; Gian Luigi Adani; Matteo Cavalletti; Sami Schiff; Annachiara Cagnin; Carlo Poci; Carlo Merkel; Piero Amodio; Sara Montagnese
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 139 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22149
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatic myelopathy (HM) is a rarely reported disorder characterized by progressive spastic paraparesis due to impaired corticospinal tract function in the setting of cirrhosis or portosystemic shunting. HM has not to date been recognized as a Model for End-Stage Liver Disease (MELD) exception for tr
In the current Model for End-Stage Liver Disease allocation system, patients are at risk of suffering repeated episodes of hepatic encephalopathy (HE) while waiting for an orthotopic liver transplantation (OLT); the posttransplantation impact of these episodes has not been well explored. We evaluate
Mixed cryoglobulinemia is a well-known complication after hepatitis C virus (HCV) infection. We report five cases in which cryoglobulinemia appeared or grossly exacerbated following orthotopic liver transplantation (OLT). Cryoglobulinemia and the associated clinical symptoms resolved or improved in
Patients with clinical acute alcoholic hepatitis (AAH) are not considered suitable candidates for orthotopic liver transplantation (OLT). The histological correlates of AAH are often seen in the explanted liver at the time of transplantation. The importance of these findings remains inconclusive reg